US Vice President-elect JD Vance underwent minor endoscopic sinus surgery at George Washington Hospital, initially planned to ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that ...

IntroductionThe demand for ENT (Ears, Nose, and Throat) treatment solutions is rising significantly due to the increasing ...

CTB-201 is under development for the treatment of chronic sinusitis. It is administered as intranasal spray. It is a preparation of recombinant human CC10 protein (rhCC10). CC10 was the most abundant ...

Respiratory system-related problems including allergic cough, flu, and aggravated asthma are on the rise in Mumbai due to fluctuating temperatures and air pollution, doctors said. Doctors suggested ...

(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.

Rhinoplasty is a surgical procedure aimed at altering the nasal aesthetics and is currently one of the most sought-after ...

Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...